Revisiting nitrates use in pre-shock state of contemporary cardiogenic shock classification.

Kaddoura, Rasha; Patel, Ashfaq; Arabi, Abdul Rahman

Kaddoura, Rasha; Patel, Ashfaq; Arabi, Abdul Rahman.

Afiliación

Kaddoura R; Pharmacy Department, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
Patel A; Department of Cardiology, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
Arabi AR; Department of Cardiology, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.

Front Cardiovasc Med ; 10: 1173168, 2023.

Article en En | MEDLINE | ID: mdl-38239875

ABSTRACT

ABSTRACT

Patients at each shock stage may behave and present differently with a spectrum of shock severity and adverse outcomes. Shock severity, shock aetiology, and several factors should be integrated in management decision-making. Although the contemporary shock stages classification provided a standardized shock severity assessment, individual agents or management strategy has not yet been studied in the context of each shock stage. The pre-shock state may comprise a wide range of presentations. Nitrate therapy has potential benefit in myocardial infarction and acute heart failure. Herein, this review aims to discuss the potential use of nitrate therapy in the context of the pre-shock state or stage B of the contemporary shock classification given its various presentations.

Palabras clave

SCAI; cardiogenic shock; isosorbide dinitrate; nitrates; nitroglycerine; pre-shock; vasodilators

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Cardiovasc Med Año: 2023 Tipo del documento: Article País de afiliación: Qatar Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google